MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery II — Presented at SCAI-ACC i2 Summit/ACC 2008 - MEND-CABG II

Description:

The goal of this trial was to evaluate treatment with pyridoxal 5’-phosphate (MC-1) compared with placebo in intermediate- to high-risk patients undergoing coronary artery bypass grafting (CABG).